//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Assistant Professor YaleIbio |ImmunoVirus❤️ | Alum @Virusesimmunity lab | #womeninSTEM
Carolina Lucas









Loading...
2/ From an mpox-convalescent individual, we isolated 3 human monoclonal antibodies (mAbs) (EV35-2, EV35-6, EV35-7) that target the extracellular virion protein A35, essential for viral spread.
9mo
Carolina Lucas
4/ Structural studies revealed all 3 mAbs target a highly conserved epitope in the A35 dimer groove, shared across orthopoxviruses. This explains their breadth and potency.
3/ These A35-specific mAbs: • Block viral spread in vitro • Protect mice from lethal mpox & vaccinia infection • Function via viral spread block + Fc-dependent mechanisms
9mo
5/ Human cohort data showed that convalescent mpox patients naturally generate A35-targeting antibodies. Higher levels of these antibodies correlated with: • Faster symptom resolution • Shorter illness • No hospitalizations
🦠 1/ The 2022 mpox outbreak underscored the urgent need for effective therapies. Existing antivirals (e.g., Tecovirimat) showed limited success in trials. We set out to identify new immune-based strategies.
7/ Together, our findings establish A35 as a critical therapeutic target for mpox and related orthopoxviruses, paving the way for next-generation antibody therapies and improved vaccines.
6/ Importantly, current smallpox/mpox vaccines (Dryvax, JYNNEOS) elicit low levels of antibodies against these protective A35 epitopes, underscoring a gap in current vaccine design.
8/ Truly an amazing team to work with. Brilliant science, (and laughs) all the way through 😂🧪” Congrats agains to @raiannafantin.bsky.social (brilliant first author) and the @camilahcoelho.bsky.social !
9mo
9mo
9mo
9mo
9mo
9mo
🚨New Paper in Cell 🧵🔎 Happy to share our work led by the @camilahcoelho.bsky.social, on mAbs against mpox. We were very excited (and lucky!) to contribute to this collab. effort. 🦠“Human monoclonal antibodies targeting A35 protect from death caused by mpox”🦠 doi.org/10.1016/j.cell.2025.08.004
Carolina Lucas
Register for #HumanImmuno26: Genes & Environment! 🗓️ 13-15 May 2026 Join researchers in #immunology, genetics, functional genomics, and physiology to exchange knowledge and explore solutions to key gaps in understanding human immune diversity. 📎 bit.ly/4rpfwpW #ImmunoGenetics #ImmunoSky 🧪💉
Carolina Lucas
9mo
Carolina Lucas
Carolina Lucas
Carolina Lucas
Carolina Lucas
Carolina Lucas
5mo
Carolina Lucas
Wellcome Connecting Science Learning and Training